Indian Market

Hyundai Motor India to Strengthen EV Charging Network with 600 Fast Chargers by 2030

Hyundai Motor India to Strengthen EV Charging Network with 600 Fast Chargers by 2030

Hyundai Motor India Ltd (HMIL) announced plans to enhance the country’s electric vehicle (EV) charging infrastructure by installing nearly 600 fast-charging stations nationwide over the next seven years. The initiative aims to address consumer concerns about long-distance EV commutes due to limited highway charging options. The company intends to use its global EV and battery […]

Hyundai Motor India to Strengthen EV Charging Network with 600 Fast Chargers by 2030 Read More »

Vodafone Idea Approves Rs 1,980 Crore Fundraising via Preferential Issue

Vodafone Idea Approves Rs 1,980 Crore Fundraising via Preferential Issue

On December 9, Vodafone Idea’s board approved a proposal to raise Rs 1,980 crore through the issuance of 176 crore shares on a preferential basis. The shares will be priced at Rs 11.28 each. The fundraising includes Rs 1,280 crore from Omega Telecom and Rs 700 crore from Usha Martin Telematics, both part of the

Vodafone Idea Approves Rs 1,980 Crore Fundraising via Preferential Issue Read More »

Godrej Consumer Shares Drop 9% After Q3 Growth Warning

Godrej Consumer Shares Drop 9% After Q3 Growth Warning

Shares of Godrej Consumer Products Limited tumbled over 9% on December 9 after the company gave a cautious outlook for the October-December quarter. The company expects mid-single-digit sales growth for Q3 and has flagged subdued economic demand conditions. It has also warned of a “temporary downward breach” in its operating margins for the quarter, along

Godrej Consumer Shares Drop 9% After Q3 Growth Warning Read More »

Investors File Plea in Delhi HC Urging Sebi to Approve NSE IPO

Investors File Plea in Delhi HC Urging Sebi to Approve NSE IPO

Investors, led by the People Activism Forum, have petitioned the Delhi High Court to direct the Securities and Exchange Board of India (Sebi) to approve the National Stock Exchange’s (NSE) long-awaited initial public offering (IPO). The plea follows Sebi’s reluctance to issue a no-objection certificate (NOC) despite NSE reapplying on August 27, according to a

Investors File Plea in Delhi HC Urging Sebi to Approve NSE IPO Read More »

Flipkart Plans IPO by 2026, Shifts Base to India for Domestic Listing: Report

Flipkart Plans IPO by 2026, Shifts Base to India for Domestic Listing: Report

Flipkart, India’s leading e-commerce platform, is preparing for an initial public offering (IPO) in the next 12-15 months, with plans to shift its corporate domicile from Singapore to India, according to reports. The Walmart-owned company, valued at $36 billion, has reportedly secured internal approvals for this strategic move, which aligns with its vision to list

Flipkart Plans IPO by 2026, Shifts Base to India for Domestic Listing: Report Read More »

Paytm Singapore to Sell Stock Acquisition Rights in PayPay for ₹2,364 Crore

Paytm Singapore to Sell Stock Acquisition Rights in PayPay for ₹2,364 Crore

Paytm’s wholly-owned subsidiary, One97 Communications Singapore Pvt Ltd (Paytm Singapore), announced the sale of its Stock Acquisition Rights (SARs) in Japan’s PayPay Corporation to SoftBank Vision Fund 2. The deal, valued at ¥41.9 billion (approximately ₹2,364 crore), is expected to conclude by December 2024, pending corporate approvals and other customary conditions. Deal Highlights Paytm’s Continued

Paytm Singapore to Sell Stock Acquisition Rights in PayPay for ₹2,364 Crore Read More »

Suven Pharma Acquires Majority Stake in US-Based NJ Bio for $64.4 Million

Suven Pharma Acquires Majority Stake in US-Based NJ Bio for $64.4 Million

Hyderabad-based Suven Pharmaceuticals has entered into definitive agreements to acquire a 56% equity stake in NJ Bio, Inc., a Contract Research, Development, and Manufacturing Organization (CRDMO) headquartered in Princeton, New Jersey. The $64.4 million transaction comprises a mix of primary equity infusion and secondary share acquisition. Key Details of the Acquisition NJ Bio is a

Suven Pharma Acquires Majority Stake in US-Based NJ Bio for $64.4 Million Read More »

Bajaj Healthcare Secures Australian TGA Approval for Gujarat API Site

Bajaj Healthcare Secures Australian TGA Approval for Gujarat API Site

Bajaj Healthcare’s manufacturing facility in Savli, Vadodara, Gujarat, has received approval from Australia’s Therapeutic Goods Administration (TGA). This achievement enhances its global credentials and allows direct supply of active pharmaceutical ingredients (APIs) to Australian and New Zealand markets. Already approved by the USFDA and the European Union, this latest certification is valid for 24 months.

Bajaj Healthcare Secures Australian TGA Approval for Gujarat API Site Read More »

IMF’s Krishnamurthy Subramanian Says: 'The world is bullish on India'

IMF’s Krishnamurthy Subramanian Says: ‘The world is bullish on India’

Krishnamurthy V Subramanian, India’s top economist and Executive Director at the International Monetary Fund (IMF), highlighted the growing global confidence in India’s economic future. In an interview, he praised India’s public digital infrastructure and its focus on inclusive growth. Subramanian noted India’s steady post-COVID growth rate of 7%, despite recent slowdowns due to reduced capital

IMF’s Krishnamurthy Subramanian Says: ‘The world is bullish on India’ Read More »

Jupiter India Fund Offloads 0.5% Stake in Himatsingka Seide

Jupiter India Fund Offloads 0.5% Stake in Himatsingka Seide, Bulk Deals Highlight Market Action

On December 6, The Royal Bank of Scotland Plc, acting as Trustee for Jupiter India Fund, sold a 0.5% stake in Himatsingka Seide at an average price of Rs 195.22 per share. This transaction, valued at Rs 13.48 crore, reduced the fund’s stake, which stood at 5.01% as of October 2024. Despite the sale, shares

Jupiter India Fund Offloads 0.5% Stake in Himatsingka Seide, Bulk Deals Highlight Market Action Read More »

Scroll to Top